Related Experiment Videos
Incident coronary revascularization and subsequent mortality in chronic heart failure: a propensity-matched study
Grigorios Giamouzis1, Syed Abbas Agha, O James Ekundayo
1Emory University, Atlanta, Georgia, USA.
International Journal of Cardiology
|December 17, 2008
Summary
Coronary revascularization in chronic heart failure patients with ischemic heart disease did not impact mortality. Propensity matching revealed no association between revascularization and survival in this high-risk group.
Area of Science:
- Cardiology
- Clinical Medicine
- Outcomes Research
Background:
- Ischemic heart disease (IHD) is a frequent comorbidity in patients with heart failure (HF).
- The impact of coronary revascularization on mortality in HF patients with IHD remains understudied, particularly using propensity-matched analyses.
Purpose of the Study:
- To investigate the association between incident coronary revascularization and mortality in patients with chronic heart failure and ischemic heart disease.
- To assess the influence of left ventricular ejection fraction (LVEF) on this association.
Main Methods:
- Utilized data from the Digitalis Investigation Group trial.
- Employed propensity score matching to create balanced cohorts of patients with and without coronary revascularization.
- Applied matched Cox regression models to estimate mortality risk during the fourth year of follow-up.
Main Results:
- Coronary revascularization was linked to higher LVEF and increased angina prevalence, but fewer prior myocardial infarctions.
- After propensity matching, all-cause mortality did not differ significantly between revascularized and non-revascularized patients (HR 0.95; 95% CI, 0.39-2.32).
- Subgroup analysis by LVEF (< or =35% and >35%) did not reveal a significant association between revascularization and mortality.
Conclusions:
- In chronic heart failure patients with IHD, coronary revascularization is associated with improved LVEF and angina symptom relief.
- Propensity-matched analysis indicates no significant impact of coronary revascularization on mortality in this patient population.
- Further prospective studies are warranted to explore the relationship between LVEF and mortality variations in HF patients undergoing revascularization.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...